4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000359
Chief Financial Officer sold 10,000 shares at an average $507.22 ($5,072,165)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hippel James · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-02 | Exercise or conversion : show line 1 in the form | +10,000 | $106.59 | $1,065,900 | 20,855 | D |
| 2021-09-02 | Sale : show line 2 in the form | −9,993 | $507.22 | $5,068,600 | 10,862 | D |
| 2021-09-02 | Sale : show line 3 in the form | −7 | $509.17 | $3,564 | 10,855 | D |
| Open-market sales · 10,000 sh · avg $507.22 · $5,072,165 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-02 | Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) | −10,000 | 0 | D |
Loading xslF345X03/edgar.xml…